Foster, David A.

Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D

Hui, L., Zheng, Y., Yan, Y., Bargonetti, J., & Foster, D. A. (2006) · Oncogene

Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 218

Suppression of Hypoxia-Inducible Factor 2α Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells

Roberts, A. M., Watson, I. R., Evans, A. J., Foster, D. A., Irwin, M. S., & Ohh, M. (2009) · Cancer Research

Cancer-related Molecular PathwaysCancer, Hypoxia, and Metabolism

Cited by 88

Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells

Patel, D., Menon, D., Bernfeld, E., Mroz, V., Kalan, S., Loayza, D., & Foster, D. A. (2016) · Journal of Biological Chemistry

Cancer, Hypoxia, and MetabolismBiochemical and Molecular Research

Cited by 86

Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells

Bernfeld, E., & Foster, D. A. (2019) · Trends in Endocrinology & Metabolism

Cancer, Hypoxia, and MetabolismAmino Acid Enzymes and Metabolism

Cited by 85

Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs

Saqcena, M., Mukhopadhyay, S., Hosny, C., Alhamed, A., Chatterjee, A., & Foster, D. A. (2015) · Oncogene

Cancer, Hypoxia, and MetabolismCancer, Lipids, and Metabolism

Cited by 67

Synthetic lethality in KRas-driven cancer cells created by glutamine deprivation

Mukhopadhyay, S., Saqcena, M., & Foster, D. A. (2015) · Oncoscience

Cancer, Hypoxia, and MetabolismPI3K/AKT/mTOR signaling in cancer

Cited by 61